Walleye Capital’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5K Sell
627
-264,271
-100% -$5.65M ﹤0.01% 4478
2026
Q1
$5.35M Buy
+264,898
New +$5.89M 0.02% 764
2025
Q3
Sell
-372,647
Closed -$8.7M 4413
2025
Q2
$7.25M Buy
372,647
+300,131
+414% +$4.44M 0.03% 665
2025
Q1
$933K Buy
72,516
+35,121
+94% +$565K ﹤0.01% 2025
2024
Q4
$644K Buy
37,395
+13,208
+55% +$264K ﹤0.01% 2771
2024
Q3
$546K Buy
24,187
+7,742
+47% +$177K ﹤0.01% 3218
2024
Q2
$406K Buy
16,445
+12,753
+345% +$362K ﹤0.01% 3680
2024
Q1
$122K Buy
+3,692
New +$126K ﹤0.01% 4284
2022
Q4
Sell
-9,984
Closed -$277K 3129
2022
Q3
$277K Sell
9,984
-69,798
-87% -$2.26M 0.01% 1890
2022
Q2
$2.36M Buy
+79,782
New +$2.68M 0.07% 317
2019
Q3
Sell
-10,500
Closed -$239K 1852
2019
Q2
$255K Buy
10,500
+2,500
+31% +$51.4K 0.03% 830
2019
Q1
$103K Buy
+8,000
New +$140K 0.02% 1022

Other funds holding ADNT

Walleye Capital's ADNT Position: Q2 2026 in Review

Walleye Capital reduced its Adient (ADNT) stake by 100% in Q2 2026, selling an estimated $5.65M and leaving 627 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4478.

Walleye Capital first reported a position in ADNT in Q1 2019 and has held it in 12 quarters since. The position peaked at $7.25M in Q2 2025. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Walleye Capital held 627 shares of Adient worth $11.5K as of Q2 2026.
  • Walleye Capital sold 264,271 Adient shares in Q2 2026, an estimated $5.65M.
  • Adient made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4478 holding.
  • Walleye Capital first reported a position in Adient in Q1 2019 and has held it in 12 quarters since.
  • Walleye Capital's Adient position peaked at $7.25M in Q2 2025.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.